A Randomized, Placebo-Controlled Trial of Latrepirdine in Huntington Disease

OBJECTIVES: To evaluate the safety and tolerability of latrepirdine in Huntington disease (HD) and explore its effects on cognition, behavior, and motor symptoms. DESIGN: Double-blind, randomized, placebo-controlled trial. SETTING: Multicenter outpatient trial. PARTICIPANTS: Ninety-one participants...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kieburtz, Karl, McDermott, Michael P., Voss, Tiffini S., Corey-Bloom, Jody, Deuel, Lisa M., Dorsey, E. Ray, Factor, Stewart, Geschwind, Michael D., Hodgeman, Karen, Kayson, Elise, Noonberg, Sarah, Pourfar, Michael, Rabinowitz, Karen, Ravina, Bernard, Sanchez-Ramos, Juan, Seely, Lynn, Walker, Francis, Feigin, Andrew
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4134015/
https://ncbi.nlm.nih.gov/pubmed/20142523
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/archneurol.2009.334
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados